Moleculin Biotech
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $63 | $126 |
Gross Profit | -21 | -29 | -31 | -31 |
EBITDA | -25,378 | -7,611 | -5,912 | -1,851 |
EBIT | -25,399 | -7,640 | -5,943 | -1,882 |
Net Income | -25,399 | -7,640 | -6,436 | -1,882 |
Net Change In Cash | 0 | 0 | 63 | 126 |
Free Cash Flow | -7,223 | -5,582 | -4,564 | -5,083 |
Cash | 6,703 | 7,557 | 7,716 | 4,278 |
Basic Shares | 1,492 | 621 | 3 | 135 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -126 | -127 | -222 | -260 |
EBITDA | -26,515 | -29,504 | -30,510 | -22,804 |
EBIT | -26,641 | -29,631 | -30,640 | -22,968 |
Net Income | -21,763 | -29,769 | -29,025 | -15,894 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,875 | -24,225 | -27,706 | -18,970 |
Cash | 4,278 | 23,550 | 43,145 | 70,903 |
Basic Shares | 137 | 79 | 76 | 71 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.68 |
2025-06-30 | -$0.49 |
2025-03-31 | -$0.69 |
2024-12-31 | -$0.55 |
